Financial Contrast: Orion OYJ (OTCMKTS:ORINY) versus Hypermarcas (OTCMKTS:HYPMY)

Orion OYJ (OTCMKTS:ORINY – Get Free Report) and Hypermarcas (OTCMKTS:HYPMY – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Profitability

This table compares Orion OYJ and Hypermarcas’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Orion OYJ 30.25% 54.09% 33.33%
Hypermarcas 20.07% 12.58% 7.00%

Dividends

Orion OYJ pays an annual dividend of $0.36 per share and has a dividend yield of 0.6%. Hypermarcas pays an annual dividend of $0.13 per share and has a dividend yield of 3.5%. Orion OYJ pays out 13.3% of its earnings in the form of a dividend. Hypermarcas pays out 25.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Volatility and Risk

Orion OYJ has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Comparatively, Hypermarcas has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Orion OYJ and Hypermarcas, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orion OYJ 0 1 0 1 3.00
Hypermarcas 0 1 0 1 3.00

Earnings & Valuation

This table compares Orion OYJ and Hypermarcas”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Orion OYJ $2.14 billion 7.42 $566.04 million $2.71 20.72
Hypermarcas $1.38 billion 1.89 $213.10 million $0.52 7.11

Orion OYJ has higher revenue and earnings than Hypermarcas. Hypermarcas is trading at a lower price-to-earnings ratio than Orion OYJ, indicating that it is currently the more affordable of the two stocks.

Summary

Orion OYJ beats Hypermarcas on 9 of the 11 factors compared between the two stocks.

About Orion OYJ

(Get Free Report)

Orion Oyj is a Finnish pharmaceutical company that develops, manufactures and markets medicines for human and veterinary use. Its portfolio includes prescription and over-the-counter medicines, as well as active pharmaceutical ingredients supplied to other pharmaceutical companies. Founded in 1917 and headquartered in Espoo, Finland, Orion has a long history in the pharmaceutical industry. The company focuses on areas including oncology, neurology and respiratory diseases, and develops some products in collaboration with international pharmaceutical partners.

About Hypermarcas

(Get Free Report)

Hypermarcas was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories. Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo QuĂ­mica and Mantecorp.

Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.